GLP-1 Access by StateLA

GLP-1 Weight Loss Medications in Louisiana

Access semaglutide and tirzepatide in Louisiana through Healthy Louisiana Medicaid, telehealth, and major health systems.

Telehealth Prescribing

Allowed

Restrictions

Louisiana enacted Act 166 (2020) making telehealth flexibilities permanent. Providers must hold a Louisiana license. Audio-video is required for initial consultations. Louisiana permits audio-only follow-ups for established patients. Telehealth parity applies to commercial and Medicaid plans.

Prescribing Rules

GLP-1 medications can be prescribed via telehealth in Louisiana after a video consultation. Louisiana does not require an in-person visit for non-controlled medications. Nurse practitioners and physician assistants can prescribe with collaborative practice agreements.

Insurance Coverage

Medicaid Coverage

Yes (expanded)

Prior Authorization

Typically required

Major Insurers

Blue Cross Blue Shield of LouisianaLouisiana Healthcare ConnectionsAetnaHumana

Louisiana expanded Medicaid in 2016 under Governor Edwards. Healthy Louisiana covers over 600,000 adults through managed care organizations. GLP-1s are covered for type 2 diabetes. Weight management coverage requires prior authorization. Louisiana has one of the highest adult obesity rates in the country at approximately 40%, making GLP-1 access a significant public health priority.

Cost Breakdown

Brand Name

$900-$1350

per month, without insurance

Compounded

Available

$175-$425

per month

Top Providers in Louisiana

Ochsner Health Weight Management

In-Person

Louisiana largest health system with comprehensive obesity medicine programs in New Orleans and Baton Rouge.

Ro

Telehealth

Serves Louisiana residents statewide with video consultations and compounded semaglutide.

LSU Health Shreveport Obesity Medicine

In-Person

Academic obesity medicine program serving northern Louisiana.

Louisiana Obesity Crisis and GLP-1 Demand

Louisiana has one of the highest adult obesity rates in the nation at approximately 40%, with some parishes exceeding 45%. The state also has high rates of type 2 diabetes, cardiovascular disease, and related conditions. This creates enormous demand for GLP-1 medications. The 2016 Medicaid expansion added over 600,000 adults to coverage, many of whom are now potential candidates for GLP-1 therapy. Healthy Louisiana managed care organizations are increasingly incorporating anti-obesity medication coverage.

Ochsner Health and Louisiana Providers

Ochsner Health System is the dominant healthcare provider in Louisiana, particularly in the New Orleans metro area and along the I-10 corridor. Ochsner operates comprehensive weight management programs that include GLP-1 prescribing, bariatric surgery, and behavioral health. LSU Health System serves northern Louisiana from Shreveport. Outside these metropolitan areas, community health centers and telehealth fill the gap.

Medicaid Coverage Under Healthy Louisiana

Healthy Louisiana (the state Medicaid program) operates through managed care organizations including Louisiana Healthcare Connections, Aetna Better Health, and AmeriHealth Caritas. All MCOs cover GLP-1 medications for type 2 diabetes. Weight management coverage is expanding but requires prior authorization with documented clinical criteria. Given Louisiana high obesity rate, the state has a strong public health incentive to expand GLP-1 access.

Over 600,000 adults covered through Medicaid expansion
GLP-1 diabetes coverage is standard across all MCOs
Weight management prior authorization requires BMI >= 30 or >= 27 with comorbidities

FAQ

Frequently Asked Questions

Healthy Louisiana covers GLP-1s for type 2 diabetes through managed care organizations. Weight management coverage is available with prior authorization under some MCOs. Coverage is expanding as the state addresses its high obesity rate.

Yes. Louisiana has permanent telehealth legislation allowing video consultations for GLP-1 prescriptions. Multiple platforms serve Louisiana residents statewide.

Ochsner Health Weight Management in New Orleans is the largest and most comprehensive program. Tulane Medical Center also offers obesity medicine services. Telehealth platforms provide additional options.

Compounded semaglutide costs $175-$425/month through telehealth platforms. Brand-name Wegovy costs $900-$1,350/month without insurance. Many Louisiana residents qualify for Medicaid coverage.